iLoF key facts
- Developer of an artificial intelligence-powered digital health platform designed to accelerate the future of personalized drug discovery and development.
- It has raised $24.2M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Google for Startups, European Innovation Council, European Commission, Quiet Capital, London & Partners. — 35 tracked in total.
- Status: Privately Held (backing).
Who backs iLoF
35+- ·The complete investor list: 35 names
- ·Watch iLoF: the Monday email on marks, rounds and moves
iLoF funding rounds
No funding rounds for iLoF are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
iLoF investors
35 investors are on record for iLoF, including Google for Startups, European Innovation Council, European Commission and Quiet Capital. By type, the record holds 4 venture capital firms and 1 family office.
About iLoF
Developer of an artificial intelligence-powered digital health platform designed to accelerate the future of personalized drug discovery and development. The company's platform uses advanced photonics to collect data to build a digital library of biomarkers and biological profiles, bringing physicists, biologists, and data scientists to study personalized treatments for patients, enabling healthcare companies to make clinical trials less expensive and patient-centric.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 39
- Website
- ilof.tech/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
iLoF doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.